Bacterial lysate for the prevention of chronic rhinosinusitis recurrence in children

Journal of Laryngology and Otology

Volumn 131, Issue 6, 2017, Pages 523-528

  Chen, J ^a   Zhou, Y ^a   Nie, J ^b   Wang, Y ^a   Zhang, L ^a   Shi, Q ^a   Tan, H ^a   Kong, W ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Children; Sinusitis; Tertiary Prevention

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM LYSATE; ANTIINFECTIVE AGENT; BRONCHO-VAXOM; CELL EXTRACT; IMMUNOLOGICAL ADJUVANT;

ACUTE RHINOSINUSITIS; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHRONIC RHINOSINUSITIS; CONTROLLED STUDY; EPIGASTRIC DISCOMFORT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE OBSTRUCTION; NOSE SECRETION; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RASH; RECURRENT DISEASE; REMISSION; TREATMENT OUTCOME; VISUAL ANALOG SCALE; CHRONIC DISEASE; COMBINATION DRUG THERAPY; PRESCHOOL CHILD; PROCEDURES; RHINITIS; SECONDARY PREVENTION; SINUSITIS;

ADJUVANTS, IMMUNOLOGIC; ANTI-BACTERIAL AGENTS; CELL EXTRACTS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RECURRENCE; RHINITIS; SECONDARY PREVENTION; SINUSITIS; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 85015652429     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215117000524     Document Type: Article

References (13)

1. Shi JB, Fu QL, Zhang H, Cheng L, Wang YJ, Zhu DD et al. Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities. Allergy 2015;70:533-9
2. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl 2012;23:1-298
3. Manning SC. Pediatric sinusitis. Otolaryngol Clin North Am 1993;26:623-38
4. Albegger K. ENT aspects of rhino-sinusitis in children (author's transl) [in German]. HNO 1980;28:321-8
5. De Benedetto F, Sevieri G. Prevention of respiratory tract infections with bacterial lysate OM-85 bronchomunal in children and adults: a state of the art. Multidiscip Respir Med 2013;8:33
6. Ahrens J. A double blind multicentre trial with BRONCHOVAXOM in adults. Atemwegs-und Lungenkrankheite 1983;9: 424-7
7. Carmona-Ramirez M A, Alvarez-Gomez V, Berber A. Use of OM-85 BV for the prevention of acute respiratory tract infections in occupational medicine. J Int Med Res 2002;30: 325-9
8. Heintz B, Schlenter WW, Kirsten R, Nelson K. Clinical efficacy of Broncho-Vaxom in adult patients with chronic purulent sinusitis-A multi-centric, placebo-controlled, double-blind study. Int J Clin Pharmacol Ther Toxicol 1989;27:530-4
9. Zagar S, L?fler-Badzek D. Broncho-Vaxom in children with rhinosinusitis: a double-blind clinical trial. ORL J Otorhinolaryngol Relat Spec 1988;50:397-404
10. Cvoriscec B, Ustar M, Pardon R, Palecek I, Stipic-Markovic A, Zimic B. Oral immunotherapy of chronic bronchitis: a doubleblind placebo-controlled multicentre study. Respiration 1989; 55:129-35
11. Orcel B, Delclaux B, Baud M, Derenne JP. Oral immunization with bacterial extracts for protection against acute bronchitis in elderly institutionalized patients with chronic bronchitis. Eur Respir J 1994;7:446-52
12. Pan L, Jiang XG, Guo J, Tian Y, Liu CT. Effects of OM-85 BV in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Clin Pharmacol 2015;55: 1086-92
13. Sedaghat AR, Phipatanakul W, Cunningham MJ. Prevalence of and associations with allergic rhinitis in children with chronic rhinosinusitis. Int J Pediatr Otorhinolaryngol 2014; 78:343-7